V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 210002207 | 210005803 | null | null | null | 2016-02-21 | 2016-03-04 | Trastuzumab | 02 | null | TRASTUZUMAB | 100576952 |
| 210002208 | 210005804 | 1.59 | 102 | Curative (C) | null | 2018-09-07 | Docetaxel | null | null | DOCETAXEL | 101518891 |
| 210002210 | 210005805 | 1.75 | 64.4 | Palliative (P) | 2017-09-16 | 2017-09-20 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100378306 |
| 210002213 | 210005807 | 1.55 | 86.2 | Adjuvant (A) | 2020-02-02 | 2020-02-02 | Docetaxel | 02 | N | DOCETAXEL | 100408370 |
| 210002214 | 210005808 | null | null | Adjuvant (A) | 2018-06-12 | 2018-06-20 | PACLITAXEL | null | N | PACLITAXEL | 101532797 |
| 210002215 | 210005809 | 1.6 | 0 | Adjuvant (A) | 2018-06-26 | 2018-07-02 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 100696132 |
| 210002219 | 210005812 | null | 72.7 | null | null | 2019-08-28 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101461123 |
| 210002220 | 210005813 | 1.6 | null | Neo-adjuvant (N) | 2018-09-28 | 2018-10-13 | Docetaxel | null | N | DOCETAXEL | 101292329 |
| 210002221 | 210005814 | 1.56 | 71 | null | 2019-02-05 | 2019-02-05 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101125890 |
| 210002222 | 210005815 | 1.53 | 62.7 | null | 2019-08-16 | 2019-08-19 | Trastuzumab | 02 | N | TRASTUZUMAB | 100996739 |
| 210002223 | 210005816 | 1.61 | 91.8 | Neo-adjuvant (N) | 2019-06-30 | 2019-09-08 | Docetaxel 100mg/m2 (21 day) | N | N | DOCETAXEL | 101536125 |
| 210002224 | 210005817 | 1.77 | 79 | Adjuvant (A) | 2021-04-13 | 2021-04-14 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101014321 |
| 210002225 | 210005818 | 1.65 | 0 | Adjuvant (A) | 2019-05-14 | 2019-10-25 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101808767 |
| 210002226 | 210005819 | null | 69 | null | 2018-11-24 | 2018-12-09 | EC | 02 | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101469952 |
| 210002227 | 210005820 | 1.65 | 76.2 | Adjuvant (A) | 2017-01-16 | 2017-01-25 | TRASTUZUMAB | null | N | TRASTUZUMAB | 101092165 |
| 210002228 | 210005821 | 1.64 | 69.4 | Adjuvant (A) | 2019-07-08 | 2019-07-08 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100034181 |
| 210002230 | 210005823 | 1.56 | 46.4 | Adjuvant (A) | 2019-02-11 | 2019-02-24 | Docetaxel | 02 | N | DOCETAXEL | 101692601 |
| 210002231 | 210005824 | 1.67 | 66.6 | Adjuvant (A) | null | 2018-08-08 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | PACLITAXEL | 100346740 |
| 210002232 | 210005825 | 1.51 | 85.8 | Adjuvant (A) | 2018-06-11 | 2018-06-13 | Docetaxel | 02 | N | DOCETAXEL | 100284759 |
| 210002233 | 210005826 | null | null | null | 2019-01-05 | 2019-01-15 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101778974 |
| 210002236 | 210005828 | 1.63 | 77.7 | Adjuvant (A) | 2019-01-20 | 2019-02-10 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 100154286 |
| 210002237 | 210005829 | 1.58 | 65 | Neo-adjuvant (N) | 2021-05-29 | 2021-06-20 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100804275 |
| 210002238 | 210005830 | 1.65 | 67.4 | Adjuvant (A) | null | 2018-08-29 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101513901 |
| 210002239 | 210005831 | null | 69 | null | 2017-02-15 | 2017-04-05 | PACLITAXEL | 02 | null | PACLITAXEL | 100277023 |
| 210002240 | 210005832 | 1.59 | 65.5 | Adjuvant (A) | 2018-07-20 | 2018-10-05 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101608610 |
| 210002241 | 210005833 | 1.67 | 100.3 | Adjuvant (A) | 2016-03-27 | 2016-07-03 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100931185 |
| 210002242 | 210005834 | 1.67 | 95.6 | Neo-adjuvant (N) | 2017-01-22 | 2017-01-22 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100285307 |
| 210002244 | 210005836 | 1.59 | 85.8 | Adjuvant (A) | 2017-05-08 | 2017-05-17 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101739653 |
| 210002246 | 210005838 | null | 47.5 | null | 2016-08-10 | 2016-08-10 | Trastuzumab Subcutaneous | 02 | null | TRASTUZUMAB | 100470498 |
| 210002248 | 210005839 | 1.66 | 46.4 | Adjuvant (A) | 2017-02-07 | 2017-02-07 | Trastuzumab Subcutaneous | null | N | TRASTUZUMAB | 101242814 |
| 210002249 | 210005840 | 1.55 | 70.6 | null | 2016-12-06 | 2016-12-16 | Docetaxel 100mg/m2 (21 day) | null | null | DOCETAXEL | 100181747 |
| 210002250 | 210005841 | 1.7 | 80.4 | Adjuvant (A) | 2017-10-12 | 2017-10-23 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100833301 |
| 210002251 | 210005842 | 1.56 | 91.7 | Adjuvant (A) | 2017-07-23 | 2017-08-02 | Docetaxel 100mg/m2 (21 day) | null | N | DOCETAXEL | 101702143 |
| 210002252 | 210005843 | 1.67 | 83 | Adjuvant (A) | 2019-03-05 | 2019-06-18 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100319799 |
| 210002256 | 210005845 | 1.65 | 62 | Adjuvant (A) | 2019-11-27 | 2019-12-26 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100276757 |
| 210002257 | 210005846 | 1.8 | 62.4 | Adjuvant (A) | 2017-11-12 | 2017-12-04 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100732879 |
| 210002259 | 210005848 | 1.63 | 71.5 | Neo-adjuvant (N) | 2019-09-04 | 2019-09-27 | EC | 02 | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101502511 |
| 210002261 | 210005850 | null | 47.2 | null | 2018-02-01 | 2018-02-21 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100016034 |
| 210002262 | 210005851 | null | null | null | 2017-07-16 | 2017-07-18 | EC | null | null | CYCLOPHOSPHAMIDE + EPIRUBICIN | 101201429 |
| 210002263 | 210005852 | null | null | null | 2017-02-11 | 2017-03-12 | Trastuzumab Subcutaneous | N | null | TRASTUZUMAB | 100038099 |
| 210002264 | 210005853 | 1.68 | null | Adjuvant (A) | null | 2016-09-24 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 100552978 |
| 210002268 | 210005856 | 1.55 | 83.2 | Adjuvant (A) | 2018-06-14 | 2018-08-25 | Docetaxel | 02 | N | DOCETAXEL | 101265629 |
| 210002269 | 210005857 | 1.73 | 68.3 | Neo-adjuvant (N) | 2019-03-27 | 2019-04-04 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100405966 |
| 210002270 | 210005858 | 1.57 | 93.8 | Adjuvant (A) | 2016-09-04 | 2016-11-22 | Docetaxel | 02 | N | DOCETAXEL | 100957857 |
| 210002271 | 210005859 | 1.61 | 54.6 | Neo-adjuvant (N) | 2017-12-19 | 2017-12-27 | Trastuzumab | N | N | TRASTUZUMAB | 100606244 |
| 210002273 | 210005860 | 1.58 | 64.2 | Adjuvant (A) | null | 2019-11-18 | EC | null | N | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100673297 |
| 210002276 | 210005861 | 1.65 | 78.75 | null | 2019-08-05 | 2019-08-21 | TRASTUZUMAB | 2 | N | TRASTUZUMAB | 100436578 |
| 210002278 | 210005863 | 1.5 | null | null | 2016-10-19 | 2016-10-19 | Trastuzumab Subcutaneous | 02 | N | TRASTUZUMAB | 101807886 |
| 210002279 | 210005864 | 1.54 | 87.6 | Neo-adjuvant (N) | null | 2018-12-22 | Trastuzumab Subcutaneous | N | N | TRASTUZUMAB | 101055554 |
| 210002280 | 210005865 | null | 39.5 | Adjuvant (A) | 2018-11-04 | 2018-11-26 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 101392213 |